Unknown

Dataset Information

0

The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis.

ABSTRACT:

SUBMITTER: Goldschmidt CH 

PROVIDER: S-EPMC7609671 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.
| S-EPMC8116391 | biostudies-literature
Unknown MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
| S-EPMC5098693 | biostudies-literature
Unknown Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort.
| S-EPMC7641290 | biostudies-literature
Unknown Can We Treat Secondary Progressive Multiple Sclerosis Now?
| S-EPMC6472227 | biostudies-literature
Unknown Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis.
| S-EPMC5497536 | biostudies-literature
Unknown Progressive multiple sclerosis.
| S-EPMC4425257 | biostudies-other
Unknown High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study.
| S-EPMC7046518 | biostudies-literature
Unknown Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
| S-EPMC8108354 | biostudies-literature
Unknown Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis.
| S-EPMC9306891 | biostudies-literature
Unknown Hepatotoxicity after high-dose intravenous methylprednisolone in multiple sclerosis patients.
| S-EPMC5538224 | biostudies-other